- Shuffle
Toggle OnToggle Off
- Alphabetize
Toggle OnToggle Off
- Front First
Toggle OnToggle Off
- Both Sides
Toggle OnToggle Off
Front
How to study your flashcards.
Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key
Up/Down arrow keys: Flip the card between the front and back.down keyup key
H key: Show hint (3rd side).h key
![]()
PLAY BUTTON
![]()
PLAY BUTTON
![]()
59 Cards in this Set
- Front
- Back
|
Mannitol is an
|
IV osmotic diuretic
|
|
spironolactone is a
|
K sparing diuretic and also
aldosterone antagonist no great boost to loops, but often combined with a loop in stage C CHF |
|
amiloride
|
a K sparing diuretic
|
|
This patient may have suffered from ethanol induced central DI – he has lost fluid, not sodium. He is not symptomatic so USe
|
dextrose 5% is best.
|
|
Loss of fluid and acedemia, give
|
Lactated Ringers - isotonic
|
|
DDAVP is a
|
vasopressin or ADH analog – it will cause increased resorption of water, with minimal effect on K.
|
|
trimethoprim (a component of sulfamethoxazole/trimethoprim or Septra) can block
|
Na+ resorption in the collecting duct, leading to retention of K (acts like a K sparing diuretic);
|
|
triamterene is a
|
K sparing diuretic.
|
|
eplerenone
|
As an aldosterone antagonist, will increase K retention.
|
|
The carbonic anhydrase inhibitors (e.g., acetazolamide) increase
|
renal secretion of bicarb and increase systemic retention of H+, causing a mild metabolic acidosis
|
|
Lithium can cause
|
nephrogenic diabetes insipidus
|
|
albuterol can cause
|
cause hypokalemia by shifting K+ intracellularly (not a renal mechanism)
|
|
amiloride
|
is a K+ sparing diuretic.
|
|
Albuterol and other beta2 agonists will cause a
|
shift of K+ intracellularly due in part to increased glucose uptake by skeletal muscle.
|
|
Calcium chloride does NOT (K)
|
reduce serum K, nor does it reduce total body K, but it antagonizes the effects of hyperkalemia.
|
|
Furosemide increases (K)
|
renal K losses
|
|
sodium polystyrene sulfonate (SPS or Kayexelate) is a
|
a K binding resin that binds to K in the gut and increases fecal losses of K – a slower route for reducing K but an effective one
|
|
Which other drugs cause an intracellular K shift?
|
Bicarb, insulin + glucose shift K
Beta 2 agonist |
|
ACEI (or ARB) are indicated in
|
diabetic patients with microalbuminurea to spare the kidneys.
|
|
Patients with diminished GFR are at risk for
|
hyperkalemia
|
|
N-acetylcysteine is effective for
|
radiocontrast induced nephropathy (bicarb is used also
|
|
Dihydroxy vitamin D3 (calcitriol) cause
|
hypercalcemia
|
|
Calcitriol promotes the absorption of
|
both Calcium from the gut, bone, and kidney
|
|
Cinacalcet is a ___ and cause__
|
a calcimimetic (not a D analog at all!) that more commonly will cause hypocalcemia
|
|
Lithium causes___ and TX
|
nephrogenic DI so Amiloride (with or without HCTZ )is the drug of choice to treat
that amiloride blocks Li uptake into cells, thereby restoring sensitivity to ADH |
|
NSAIDs have been used to treat
|
lithium induced NDI
|
|
conaVAPtAN is a
|
VAsoPressin ANtagonist
|
|
demeclocycline
|
CAUSES NDI
|
|
DDAVP is used only for
|
central DI, where the problem is a lack of ADH, not loss of response to ADH
|
|
For men with incontinence related to BPH (overflow incontinence. TX?
|
alpha 1 antagonists are generally most effective
|
|
they are generally used if the patient has BPH and/or overflow combined with hypertension
|
doxazosin
|
|
is characterized by frequent urination due to increased bladder smooth muscle tone
|
urge incontinence in women
TX: antimuscarinics |
|
Loop diuretics and Ca
|
Loop diuretics increase urinary calcium loss,
|
|
thiazides and Ca
|
thiazides (hydrochlorothiazide, metolazone) cause calcium retention.
|
|
Carbonic anhydrase inhibitors
|
inhibitors increase urinary calcium too, but aren’t very potent (therefore loop is the best answer)
|
|
Sevalemer is a
|
phosphate binder and give it with meals.
|
|
Ergocalciferol and paricalcitol are
|
D2 analogs which will increased calcium and phosphate absorption from the gut
|
|
Sodium polystyrene sulfonate is a
|
K binder, not a PO4 binder.
|
|
Which phosphate binders can reduce PO4, increase calcium, and address acidemia?
|
Calcium acetate and bicarb are used to address all 3, but calciphylaxis may occur
|
|
Milk of magnesia contains
|
Mg
|
|
Digoxin may accumulate
|
accumulate in renally impaired patients, but you’d be more likely to see nausea/vomiting, hyperkalemia disturbances of vision (yellow vision), and arrhythmia.
Since digoxin inhibits Na/K ATPase, in toxicity K accumulates extracellularly |
|
Sodium polystyrene sulfonate is
|
cation binding resin that removes K from the gut
|
|
Furosemide is likely to cause
|
ototoxicity and dehydration (in patients who can’t access water)
|
|
What drug?
SE: false elevation of Screatine |
SMX/TMP
|
|
SE?
SMX/TMP |
SE: false elevation of Screatine
|
|
What drug?
HYperCa |
HcTHZ
(SMX/TMP) |
|
SE?
HcTHZ (SMX/TMP) |
HYperCa
|
|
What drug?
SE: HypoMg |
furosemide
HCTHZ Amphoteracin B Gentamicin radiocontrast |
|
SE?
furosemide HCTHZ Amphoteracin B Gentamicin radiocontrast |
Cause HypoMg
|
|
What drug?
SE; nephrolithiasis and obstructive nephropathy |
Indinavir
SMX/TMP |
|
SE?
Indinavir SMX/TMP |
SE; nephrolithiasis and obstructive nephropathy
|
|
What drug?
SE: Hypervolemic or euvolemic Hyponatremia SIADH |
Fluoxetine
DDAVP/desmopressin |
|
SE?
Fluoxetine DDAVP/desmopressin |
SE: Hypervolemic or euvolemic Hyponatremia
|
|
What drug?
SE: ATN (intrinsic damage) |
Amphoteracin B
Gentamicin radiocontrast |
|
SE?
Amphoteracin B Gentamicin radiocontrast |
ATN (intrinsic damage)
|
|
What drug?
SE: Hypocalcemia |
furosemide
cincacalcet |
|
SE?
furosemide cincacalcet |
Hypocalcemia
|
|
What drug?
SE: NDI |
Lithium
ethanol demelocycline |
|
SE?
Lithium ethanol demelocycline |
NDI
|